| Description |
1 online resource (xviii, 417 pages) : illustrations (some color) |
| Contents |
Part I: Special situations of controversial, increased, or unknown cardiovascular risk. New risk factors of cardiovascular disease -- Angiographic narrowing prior to ST elevation MI. Are the lesions non obstructive? -- Vulnerable plaques versus patients-how to reduce acute coronary events in the future -- Diabetes and coronary artery disease -- Elevated triglycerides, atherosclerosis and adverse clinical events -- Patent foramen ovale closure and stroke -- Part II: Cardiovascular diagnosis -- CT angiography versus routine stress testing for patients with chest pain seen in the emergency room to exclude significant coronary artery disease -- Takotsubo cardiomyopathy: an interesting and somewhat unexplained clinical entity -- Chest pain in women: evaluation and management -- Part III: Cardiovascular management. Myocardial infarction diagnosis, troponin elevation and angiographic coronary artery disease -- New therapeutic options for patients with refractory angina -- Medical and invasive management of coronary artery disease in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Coronary stenting remains the first revascularization option in most patients with a clinical indication for myocardial revascularization -- Optimal management of multivessel CAD: PCI versus CABG surgery versus medical therapy alone -- Percutaneous coronary intervention in unprotected left main stenosis: medical evidence from randomized and observational studies -- Technical aspects of left main stem percutaneous coronary intervention -- DAPT after stenting in stable and acute coronary syndromes- does the drug combination really matter? -- Invasive management in CAD patients with stage 4 renal dysfunction or on dialysis -- What is the optimal stent design? The pathologist's opinion -- What is the optimal stent design interventionalist's view -- Role of oral therapies in the prevention of coronary restenosis: insights from randomized clinical trials -- When should ablation be considered in the treatment of atrial fibrillation -- a clinician's view -- Radial and femoral access in percutaneous intervention -- Advanced and expensive cardiovascular procedures in the very elderly--can we or should we limit access? -- Cost-benefit of TAVR: should indications be expanded? -- Editorial comments on the chapters |
| Summary |
"This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients"--Publisher's description |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from resource home page (ebrary, viewed February 23, 2016) |
| Subject |
Cardiology.
|
|
Heart -- Diseases.
|
|
Cardiovascular system -- Diseases.
|
|
Cardiovascular Diseases
|
|
Cardiology
|
|
Heart Diseases
|
|
Surgical techniques.
|
|
Cardiothoracic surgery.
|
|
Cardiovascular medicine.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Cardiovascular system -- Diseases
|
|
Cardiology
|
|
Heart -- Diseases
|
| Form |
Electronic book
|
| Author |
Ambrose, John A., editor.
|
|
Rodríguez, Alfredo E., editor.
|
| ISBN |
9783319204154 |
|
3319204157 |
|
